The state of insulin pump therapy: 2002

This publication has 14 references indexed in Scilit:

• Comparison of Insulin Aspart With Buffered Regular Insulin and Insulin Lispro in Continuous Subcutaneous Insulin Infusion
  Diabetes Care, 2002
• A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump
  Journal of Diabetes and its Complications, 2001
• Beneficial Effects of Continuous Subcutaneous Insulin Infusion in Older Patients with Long-Standing Type 1 Diabetes
  Endocrine Practice, 2001
• Efficacy, Safety, and Pump Compatibility of Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 1 Diabetes
  Diabetes Care, 2001
• Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
  Diabetes, 2000
• Efficacy of Insulin Pump Therapy: Mealtime Delivery is the Key Factor
  Endocrine Practice, 2000
• Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use
  Diabetes Technology & Therapeutics, 2000
• Comparison of Metabolic Deterioration between Insulin Analog and Regular Insulin after a 5-Hour Interruption of a Continuous Subcutaneous Insulin Infusion in Type 1 Diabetic Patients
  Journal of Clinical Endocrinology & Metabolism, 1999
• Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.
  Diabetes Care, 1999
• Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes
  Diabetes Care, 1996